Back in 2024, a system set up to identify objects that suddenly brighten found something unusual. Unfortunately, the automated system that was supposed to identify it couldn't figure out what it was looking at. Now, about a year later, we know it's the first tidal disruption event—meaning a star being ripped apart by a supermassive black hole—identified at visual wavelengths. It's also a rather unusual one, in that the supermassive black hole in question does not reside at the center of its galaxy. Instead, there's an even more massive object there, which is feeding on matter at the same time.

A mystery object

The object, now called AT2024tvd, was identified by the Zwicky Transient Facility , which is set up to scan the entire northern sky over a period of just two days, after which it repeats the process. Combined with software that scans the data for changes, these repeated exposures allow the system to identify objects that suddenly brighten (or, potentially, anything that suddenly goes dark). Among the events it can identify are tidal disruption events, where a star gets spaghettified by the enormous gravity of a supermassive black hole.

Normally, supermassive black holes live at the center of galaxies. So, the software that does the scanning will only flag something as a potential tidal disruption event if it coincides with the presence of a previous light source at the same location. And that wasn't the case with AT2024tvd, which appeared to be over 2,500 light years from the center of the galaxy. As a result, the software didn't flag it as a potential tidal disruption event; people didn't figure out what it was until they looked more closely at it.

Read full article

Comments

Back in 2024, a system set up to identify objects that suddenly brighten found something unusual. Unfortunately, the automated system that was supposed to identify it couldn't figure out what it was looking at. Now, about a year later, we know it's the first tidal disruption event—meaning a star being ripped apart by a supermassive black hole—identified at visual wavelengths. It's also a rather unusual one, in that the supermassive black hole in question does not reside at the center of its galaxy. Instead, there's an even more massive object there, which is feeding on matter at the same time.

A mystery object

The object, now called AT2024tvd, was identified by the Zwicky Transient Facility , which is set up to scan the entire northern sky over a period of just two days, after which it repeats the process. Combined with software that scans the data for changes, these repeated exposures allow the system to identify objects that suddenly brighten (or, potentially, anything that suddenly goes dark). Among the events it can identify are tidal disruption events, where a star gets spaghettified by the enormous gravity of a supermassive black hole.

Normally, supermassive black holes live at the center of galaxies. So, the software that does the scanning will only flag something as a potential tidal disruption event if it coincides with the presence of a previous light source at the same location. And that wasn't the case with AT2024tvd, which appeared to be over 2,500 light years from the center of the galaxy. As a result, the software didn't flag it as a potential tidal disruption event; people didn't figure out what it was until they looked more closely at it.

Read full article

Comments

Back in 2024, a system set up to identify objects that suddenly brighten found something unusual. Unfortunately, the automated system that was supposed to identify it couldn't figure out what it was looking at. Now, about a year later, we know it's the first tidal disruption event—meaning a star being ripped apart by a supermassive black hole—identified at visual wavelengths. It's also a rather unusual one, in that the supermassive black hole in question does not reside at the center of its galaxy. Instead, there's an even more massive object there, which is feeding on matter at the same time.

A mystery object

The object, now called AT2024tvd, was identified by the Zwicky Transient Facility , which is set up to scan the entire northern sky over a period of just two days, after which it repeats the process. Combined with software that scans the data for changes, these repeated exposures allow the system to identify objects that suddenly brighten (or, potentially, anything that suddenly goes dark). Among the events it can identify are tidal disruption events, where a star gets spaghettified by the enormous gravity of a supermassive black hole.

Normally, supermassive black holes live at the center of galaxies. So, the software that does the scanning will only flag something as a potential tidal disruption event if it coincides with the presence of a previous light source at the same location. And that wasn't the case with AT2024tvd, which appeared to be over 2,500 light years from the center of the galaxy. As a result, the software didn't flag it as a potential tidal disruption event; people didn't figure out what it was until they looked more closely at it.

Read full article

Comments

Welcome to Edition 7.43 of the Rocket Report! There's been a lot of recent news in hypersonic testing. We cover some of that in this week's newsletter, but it's just a taste of the US military's appetite for fielding its own hypersonic weapons, and conversely, the Pentagon's emphasis on the detection and destruction of an enemy's hypersonic missiles. China has already declared its first hypersonic weapons operational, and Russia claims to have them, too. Now, the Pentagon is finally close to placing hypersonic missiles with combat units. Many US rocket companies believe the hypersonics sector is a lucrative business. Some companies have enough confidence in this emerging market —or lack of faith in the traditional space launch market —to pivot entirely toward hypersonics. I'm interested in seeing if their bets pay off.

As always, we welcome reader submissions . If you don't want to miss an issue, please subscribe using the box below (the form will not appear on AMP-enabled versions of the site). Each report will include information on small-, medium-, and heavy-lift rockets, as well as a quick look ahead at the next three launches on the calendar.

Stratolaunch tests reusable hypersonic rocket plane. Stratolaunch has finally found a use for the world's largest airplane. Twice in the last five months, the company launched a hypersonic vehicle over the Pacific Ocean, accelerated it to more than five times the speed of sound, and autonomously landed at Vandenberg Space Force Base in California, Ars reports . Stratolaunch used the same Talon-A vehicle for both flights, demonstrating its reusability, a characteristic that sets it apart from competitors. Zachary Krevor, Stratolaunch's president and CEO, said his team aims to ramp up to monthly flights by the end of the year.

Read full article

Comments

Welcome to Edition 7.43 of the Rocket Report! There's been a lot of recent news in hypersonic testing. We cover some of that in this week's newsletter, but it's just a taste of the US military's appetite for fielding its own hypersonic weapons, and conversely, the Pentagon's emphasis on the detection and destruction of an enemy's hypersonic missiles. China has already declared its first hypersonic weapons operational, and Russia claims to have them, too. Now, the Pentagon is finally close to placing hypersonic missiles with combat units. Many US rocket companies believe the hypersonics sector is a lucrative business. Some companies have enough confidence in this emerging market —or lack of faith in the traditional space launch market —to pivot entirely toward hypersonics. I'm interested in seeing if their bets pay off.

As always, we welcome reader submissions . If you don't want to miss an issue, please subscribe using the box below (the form will not appear on AMP-enabled versions of the site). Each report will include information on small-, medium-, and heavy-lift rockets, as well as a quick look ahead at the next three launches on the calendar.

Stratolaunch tests reusable hypersonic rocket plane. Stratolaunch has finally found a use for the world's largest airplane. Twice in the last five months, the company launched a hypersonic vehicle over the Pacific Ocean, accelerated it to more than five times the speed of sound, and autonomously landed at Vandenberg Space Force Base in California, Ars reports . Stratolaunch used the same Talon-A vehicle for both flights, demonstrating its reusability, a characteristic that sets it apart from competitors. Zachary Krevor, Stratolaunch's president and CEO, said his team aims to ramp up to monthly flights by the end of the year.

Read full article

Comments

Welcome to Edition 7.43 of the Rocket Report! There's been a lot of recent news in hypersonic testing. We cover some of that in this week's newsletter, but it's just a taste of the US military's appetite for fielding its own hypersonic weapons, and conversely, the Pentagon's emphasis on the detection and destruction of an enemy's hypersonic missiles. China has already declared its first hypersonic weapons operational, and Russia claims to have them, too. Now, the Pentagon is finally close to placing hypersonic missiles with combat units. Many US rocket companies believe the hypersonics sector is a lucrative business. Some companies have enough confidence in this emerging market —or lack of faith in the traditional space launch market —to pivot entirely toward hypersonics. I'm interested in seeing if their bets pay off.

As always, we welcome reader submissions . If you don't want to miss an issue, please subscribe using the box below (the form will not appear on AMP-enabled versions of the site). Each report will include information on small-, medium-, and heavy-lift rockets, as well as a quick look ahead at the next three launches on the calendar.

Stratolaunch tests reusable hypersonic rocket plane. Stratolaunch has finally found a use for the world's largest airplane. Twice in the last five months, the company launched a hypersonic vehicle over the Pacific Ocean, accelerated it to more than five times the speed of sound, and autonomously landed at Vandenberg Space Force Base in California, Ars reports . Stratolaunch used the same Talon-A vehicle for both flights, demonstrating its reusability, a characteristic that sets it apart from competitors. Zachary Krevor, Stratolaunch's president and CEO, said his team aims to ramp up to monthly flights by the end of the year.

Read full article

Comments

Far fewer babies went to the hospital struggling to breathe from RSV, a severe respiratory infection, after the debut of a new vaccine and treatment this season, according to an analysis published today by the Centers for Disease Control and Prevention .

RSV, or respiratory syncytial (sin-SISH-uhl) virus, is the leading cause of hospitalization for infants in the US. An estimated 58,000–80,000 children younger than 5 years old are hospitalized each year. Newborns—babies between 0 and 2 months—are the most at risk of being hospitalized with RSV. The virus circulates seasonally, typically rising in the fall and peaking in the winter, like many other respiratory infections.

But the 2024–2025 season was different—there were two new ways to protect against the infection. One is a maternal vaccine, Pfizer's Abrysvo, which is given to pregnant people when their third trimester aligns with RSV season (generally September through January). Maternal antibodies generated from the vaccination pass to the fetus in the uterus and can protect a newborn in the first few months of life. The other new protection against RSV is a long-acting monoclonal antibody treatment, nirsevimab, which is given to babies under 8 months old as they enter or are born into their first RSV season and may not be protected by maternal antibodies.

Read full article

Comments

Far fewer babies went to the hospital struggling to breathe from RSV, a severe respiratory infection, after the debut of a new vaccine and treatment this season, according to an analysis published today by the Centers for Disease Control and Prevention .

RSV, or respiratory syncytial (sin-SISH-uhl) virus, is the leading cause of hospitalization for infants in the US. An estimated 58,000–80,000 children younger than 5 years old are hospitalized each year. Newborns—babies between 0 and 2 months—are the most at risk of being hospitalized with RSV. The virus circulates seasonally, typically rising in the fall and peaking in the winter, like many other respiratory infections.

But the 2024–2025 season was different—there were two new ways to protect against the infection. One is a maternal vaccine, Pfizer's Abrysvo, which is given to pregnant people when their third trimester aligns with RSV season (generally September through January). Maternal antibodies generated from the vaccination pass to the fetus in the uterus and can protect a newborn in the first few months of life. The other new protection against RSV is a long-acting monoclonal antibody treatment, nirsevimab, which is given to babies under 8 months old as they enter or are born into their first RSV season and may not be protected by maternal antibodies.

Read full article

Comments

Far fewer babies went to the hospital struggling to breathe from RSV, a severe respiratory infection, after the debut of a new vaccine and treatment this season, according to an analysis published today by the Centers for Disease Control and Prevention .

RSV, or respiratory syncytial (sin-SISH-uhl) virus, is the leading cause of hospitalization for infants in the US. An estimated 58,000–80,000 children younger than 5 years old are hospitalized each year. Newborns—babies between 0 and 2 months—are the most at risk of being hospitalized with RSV. The virus circulates seasonally, typically rising in the fall and peaking in the winter, like many other respiratory infections.

But the 2024–2025 season was different—there were two new ways to protect against the infection. One is a maternal vaccine, Pfizer's Abrysvo, which is given to pregnant people when their third trimester aligns with RSV season (generally September through January). Maternal antibodies generated from the vaccination pass to the fetus in the uterus and can protect a newborn in the first few months of life. The other new protection against RSV is a long-acting monoclonal antibody treatment, nirsevimab, which is given to babies under 8 months old as they enter or are born into their first RSV season and may not be protected by maternal antibodies.

Read full article

Comments